PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

Logo of oncotargetLink to Publisher's site
 
From:
Published online 2017 February 3. doi: 10.18632/oncotarget.15043

Table 2

Overview of candidate mutations across seven paired meningioma samples
Case 1Case 2Case 3Case 4Case 5Case 6Case 7
Chrom lossa
 Chrom 1Loss
 Chrom 2Loss
 Chrom 22LossLossLoss
CNVs
 NF2DelbDelDel
 SMARCB1DelDelDel
 CHECK2DelDelDel
 OtherseBID, BIK, HDAC10, BRD1BARD1, SMARCAL1BARD1, SMARCAL1, CASP8, CASP10, DAXXBID, BIK, HDAC10, BRD1, HDAC1, ARID1A, KDM1A, KDM4ANOTCH4BID, BIK, HDAC10, BRD1, BARD1, DAXX
SNVs
 NF2Truncc
 SMARCB1Mutd
 CHECK2Mut
 NOTCH2Mut
 TRAF7MutMutMut
 AKT1MutMut
 OtherseDDR1, NF1, BCL11A, ATF6BN4BP1KMT2C, ATF2NEDD4LDRD4, CHECK2

Chrom lossa, Delb, Truncc, and Mutd mean loss of chromosome fragments, deletion, truncation and mutation respectively. NF2, SMARCB1, CHECK2, NOTCH2, TRAF7 and AKT1 are known meningioma-driver mutations. Othere are candidates identified in this study.